Sunscreen TEAs Could Illuminate How Deadlines Influence FDA’s Process
This article was originally published in The Tan Sheet
Executive Summary
CHPA says FDA’s work on sunscreen TEAs under deadlines already set will give an idea of the impact from changes Congress imposed for FDA’s TEA process. But the industry will not know whether the changes benefit introducing other new OTC ingredients until FDA establishes and follows process deadlines.